Taiwan FDA registration 7276e2c5fc0fa462f8f16d27f08d6fad

"Sturz" extracorporeal shock wave therapy system

TW: “斯特茲”體外震波治療系統
Taiwan flagTaiwan·Risk Class 2·Storz Medical AG·Registered Mar 10, 2015 – Mar 10, 2030Active
Registration details
Analysis ID
7276e2c5fc0fa462f8f16d27f08d6fad
Customs Code
DHA05602711109
Company information
Manufacturer
Storz Medical AG
Manufacturer Country
Switzerland
Authorized Representative
KINDMED CORPORATION
Product details
Intended Use
Urology is used to treat chronic pelvic pain syndrome, CPPS/chronic nonbacterial prostatitis, and vascular erectile dysfunction.
Product Type (Level 1)
H Gastroenterology and urology
Product Type (Level 2)
H.5990 體外震波碎石器
Import Information
import
Dates and status
Registration Date
Mar 10, 2015
Expiry Date
Mar 10, 2030
Companies making similar products

Top companies providing products similar to ""Sturz" extracorporeal shock wave therapy system"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for "Sturz" extracorporeal shock wave therapy system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7276e2c5fc0fa462f8f16d27f08d6fad and manufactured by Storz Medical AG. The authorized representative in Taiwan is KINDMED CORPORATION.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including STORZ MEDICAL AG, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations